Biotech VC Funds

DNS Capital is the investment office for Gigi Pritzker and her husband Michael Pucker, based in Chicago. Founded in 2014, DNS Capital invests across various stages and industries, emphasizing long-term partnerships and strategic growth. The firm has a diverse portfolio with significant investments in technology, healthcare, and industrial sectors. Notable investments include Hero Bread, which focuses on producing low-carb bakery products; IMIDomics, a biotech company working on therapeutics for immune-mediated inflammatory diseases; and Jetti Resources, which has developed a novel technology for metal extraction from ores. Other key investments include Recogni, a company specializing in high-performance computer chips for autonomous vehicles, and PayNearMe, a platform enhancing payment experiences for businesses and their customers​​. DNS Capital's approach combines financial support with strategic guidance, leveraging the deep expertise of its leadership team. They focus on building strong relationships with business owners and management teams to drive sustainable growth and innovation across their portfolio companies​.

Dolby Family Ventures is an early-stage venture capital firm that focuses on building technology companies. Established in honor of Ray Dolby, the firm aims to support innovators at the seed stage of development, partnering with strong investment syndicates to bring breakthrough technologies to market. Dolby Family Ventures has a diverse portfolio that includes companies in sectors such as biotech, healthcare IT, cybersecurity, and sustainability. Key investments include Athira Pharma, which focuses on neurodegenerative disease therapies, and Hyperfine Research, known for its portable MRI systems. Other notable investments are Switch Therapeutics, which develops RNAi therapies, and MedCrypt, specializing in healthcare cybersecurity. The firm has also seen successful exits, such as Basis Science, acquired by Intel, and goBalto, acquired by Oracle. Dolby Family Ventures works actively with entrepreneurs, offering support in operational finance, strategy, and board development, ensuring that the startups they invest in have the best chances of success. They are committed to fostering innovation that solves significant global challenges​.

Domain Capital Group, founded in 1985, specializes in biotechnology investments, managing a substantial $2.8 billion in assets. They have funded 194 companies in the biopharma, medical device, and diagnostic sectors, resulting in 90 IPOs and 110 M&A events. Notable companies in their portfolio include Zipline, GitLab, and DigitalOcean. Domain Capital’s strategy focuses on long-term partnerships and a diversified asset approach, investing in real estate, natural resources, media, entertainment, technology, and special situations to achieve stable, cash-on-cash returns. They operate globally with a team led by seasoned partners like James Blair and Brian Halak. Their investment process involves rigorous due diligence, strategic transaction structuring, and active asset management to ensure value creation and capital preservation. Domain Capital typically engages in growth and late-stage investments, leveraging their extensive industry experience and strong relationships to source and manage deals effectively. The firm’s hands-on approach includes personalized investor engagement, aiming to meet specific investment goals such as targeted returns and risk mitigation. This comprehensive strategy positions Domain Capital as a trusted partner for public and private pension plans, corporations, foundations, endowments, and high-net-worth individuals.

Dorm Room Fund (DRF), founded in 2012 by Josh Kopelman under the auspices of First Round Capital, is a venture capital firm that focuses on investing in student-run startups. Headquartered in Cambridge, Massachusetts, DRF has made over 400 investments and has achieved 145 exits. Notable exits include MetaMap, DiscreetAI, WorkerSense, and ScienceIO. DRF’s mission is to support student founders by providing access to a powerful investor network, world-class mentors, and essential capital to accelerate their growth. The fund has supported over 300 companies led by student founders, including prominent names like Athelas and WellTheory. Dorm Room Fund is dedicated to promoting diversity, equity, and inclusion within the venture capital industry. Nearly 80% of their alumni go on to become founders or venture capitalists themselves. The fund has created initiatives like the Blueprint Project and the Female Founder Track to empower underrepresented students. The investment team at DRF consists of student partners who bring unique insights into the next wave of groundbreaking companies. This model allows them to identify promising startups that might be overlooked by traditional investors.

Dow Venture Capital, a corporate venture arm of Dow Inc., focuses on strategic investments that align with Dow's broader goals of sustainability and innovation. Established in 1994, the unit is headquartered in Midland, Michigan, and targets a range of sectors including clean technology, advanced materials, recycling, and healthcare. Their investments often seek to advance circular economy solutions, such as their partnerships with companies like Plastogaz, which aims to simplify plastic recycling processes through advanced catalytic technology, and Mura Technology, which focuses on chemical recycling for hard-to-recycle plastics. Dow Venture Capital also collaborates with companies in the fields of renewable energy, water treatment, and sustainable agriculture, demonstrating their commitment to tackling global environmental challenges. With a presence across North America, Europe, and Asia, their approach blends Dow’s extensive materials science expertise with innovative startup technologies, facilitating solutions that can scale globally. Dow's focus on recycling has led to investments that aim to close the loop on plastic waste, ensuring materials can be reused sustainably​. Overall, Dow Venture Capital plays a key role in Dow’s strategic direction by supporting startups that drive growth and value, particularly in areas that complement their sustainability mission and core business sectors.

Downing LLP is a UK-based investment management firm that emphasizes sustainable and impactful investments across various sectors. Established in 1986, Downing manages around £2 billion in assets, offering a diverse range of investment strategies. It has built a reputation for responsible investing, holding a B Corp certification, which underscores its commitment to balancing profit with social and environmental responsibility. Downing Ventures, a division of Downing LLP, focuses on early to growth-stage technology companies. Their investment portfolio spans sectors including healthcare, clean technology, and software, with a preference for businesses that integrate sustainability and innovative solutions. Recent initiatives include the appointment of Dr. Nigel Pitchford as Head of Healthcare Ventures, reflecting their strategic focus on med-tech and life sciences. This division has supported over 20 healthcare companies, deploying more than £36 million since 2014. In addition to venture capital, Downing also invests in renewable energy projects, infrastructure, and property finance. They operate the Downing Renewables & Infrastructure Trust (DORE), which funds solar, wind, and energy storage projects across the UK and Northern Europe. Through these ventures, Downing aims to deliver stable returns while promoting environmental sustainability​.

DRADS Capital is a Boston-based venture capital firm focused on investing in groundbreaking innovations within the life sciences, biotechnology, and artificial intelligence sectors. The firm is driven by a mission to back visionary entrepreneurs who are pushing the boundaries of science and technology to create a healthier future. DRADS Capital targets early to late-stage companies that offer transformative solutions to some of the world's most challenging health problems. Founded by A. Nagarajan Pillay, a seasoned entrepreneur with over 25 years of experience, DRADS Capital has built a diverse portfolio that includes companies specializing in areas such as organ regeneration, precision fermentation, and AI-driven healthcare solutions. The firm is known for its hands-on approach, working closely with startups to navigate the complexities of bringing innovative healthcare products to market. DRADS Capital operates with a small, tight-knit team of experts who are deeply involved in every aspect of the investment process. This team includes professionals with backgrounds in law, venture capital, and global business development, all contributing to the firm's strategic vision.

Dragon Capital is a leading investment firm specializing in emerging markets, with a strong focus on Vietnam and Southeast Asia. Established in 1994, the firm has built a reputation as a trusted financial partner for both local and international investors. Dragon Capital provides a wide range of financial services, including asset management, private equity, fixed income, and real estate investment, making it one of the most prominent players in the region’s financial landscape. With a deep understanding of the Southeast Asian market, Dragon Capital is known for its ability to identify high-potential investment opportunities across various sectors, including technology, infrastructure, energy, and consumer goods. The firm’s investment philosophy revolves around a long-term, research-driven approach, aiming to generate sustainable returns while contributing to the development and modernization of the region’s economy. Dragon Capital’s success is attributed to its team of seasoned professionals who possess a wealth of experience in global financial markets and in-depth knowledge of local industries. This expertise allows the firm to offer investors tailored solutions that align with their risk appetite and financial goals. The firm is committed to maintaining the highest standards of transparency, governance, and sustainability in all of its investments. In addition to financial performance, Dragon Capital places a strong emphasis on environmental, social, and governance (ESG) factors. The firm is dedicated to responsible investing, seeking to foster positive social and environmental impacts alongside financial returns. As Southeast Asia continues to grow, Dragon Capital remains at the forefront of shaping its economic future.

Draper Associates, founded in 1985 by Tim Draper, is a renowned early-stage venture capital firm based in Silicon Valley. The firm has made significant investments in transformative companies across various sectors, including technology, consumer services, and financial services. Draper Associates is known for its notable investments in companies like Hotmail, Skype, Tesla, SpaceX, Twitch, Robinhood, Coinbase, and Baidu. The firm focuses on backing innovative startups with the potential for extraordinary outcomes, often investing at the seed stage and supporting companies through their growth journeys. Draper Associates prides itself on being entrepreneur-friendly, providing extensive support and resources to help founders succeed. Draper Associates is part of the larger Draper Ecosystem, which includes Draper University, Draper Venture Network, and Draper Startup House, among other initiatives aimed at fostering entrepreneurial growth and innovation globally. The firm's investment philosophy emphasizes a global perspective, investing in industry-transforming companies across the world while maintaining a strong presence in Silicon Valley. Draper Associates continues to innovate and drive significant impact in the venture capital landscape by backing visionary entrepreneurs and leveraging its extensive network and resources.

The Drawdown Fund is a growth equity investment firm focused on businesses that address the key drivers of climate change. Co-founded by the renowned environmentalist Paul Hawken, the fund leverages robust climate models and research to guide its investment strategy. The Drawdown Fund targets companies that have proven technology, established revenue, strong growth, and a clear competitive advantage, typically investing between $10 million and $30 million. The fund is particularly interested in companies that are actively reducing carbon emissions or sequestering greenhouse gases. Their investment focus spans three major systems: Energy Transition, Resilient Systems, and Sustainable Cities. These sectors include technologies like smart grids, renewable energy, sustainable food and agriculture, and urban decarbonization. The Drawdown Fund prides itself on its deep industry knowledge and a strong network of operators, entrepreneurs, and researchers who provide value beyond capital. The team has over 50 years of combined experience in sustainability and growth investing, ensuring a hands-on approach with each portfolio company. They also maintain a low partner-to-portfolio company ratio, allowing for tailored support and active governance. This strategy is tightly aligned with the fund’s mission to generate both financial returns and significant positive impacts on global warming, with management carry incentives directly tied to emissions reductions or sequestration. This makes the Drawdown Fund a compelling partner for companies focused on sustainability and climate solutions.

Dreamers VC, founded by Will Smith and Keisuke Honda, is a venture capital firm based in Los Angeles, focusing on early-stage investments across various sectors including health biotech, finance tech, consumer products, and entertainment. Since its inception, Dreamers VC has built a diverse portfolio of innovative companies. Their notable investments include Beam Therapeutics, which is pioneering precision genetic medicines; Nurx, providing personalized healthcare solutions delivered directly to consumers; and Sandbox VR, offering immersive group virtual reality experiences. Other significant investments include HomeCourt, a basketball training app, and Public, a platform for investing in crypto assets. Dreamers VC emphasizes community and leveraging their global network to connect founders with valuable resources. Their approach combines financial support with strategic guidance, ensuring startups have the tools they need to grow and succeed in competitive markets.

Dreamit Ventures is a leading venture capital firm that focuses on early-stage investments in Healthtech and Securetech startups. Founded in 2008, Dreamit has invested in over 350 companies, helping them scale revenues and achieve significant growth. Notable investments include SeatGeek, Redox, Eko, and Trendkite. Dreamit typically invests in companies that already have revenue or pilots, focusing on those ready to scale rapidly. The firm provides substantial support through its Customer Sprints® and Investor Sprints®, connecting founders with potential customers and investors. This approach helps startups gain traction and secure additional funding. Dreamit’s portfolio companies benefit from deep vertical expertise in cybersecurity, healthcare, and digital health, among other sectors. The firm is headquartered in New York and has a strong presence in the venture capital ecosystem, with a wide network of partners and advisors. Dreamit's investments are characterized by a focus on transformative technology and innovative solutions that address critical needs in their respective industries. For startups looking to engage with Dreamit, it is essential to demonstrate a clear path to revenue growth and scalability. The firm values strong, actionable business plans and provides ongoing support to help companies navigate the challenges of early-stage growth.

Drive Capital is a prominent venture capital firm based in Columbus, Ohio, founded in 2013 by Mark Kvamme and Chris Olsen, both of whom previously worked at Sequoia Capital. The firm focuses on investing in technology startups outside of Silicon Valley, with a particular emphasis on the Midwest, aiming to prove that world-class technology companies can emerge from any region in the United States. Drive Capital has raised over $2 billion to invest in startups solving significant problems in large markets. They have backed more than 80 companies, including notable investments like Duolingo, Root Insurance, Olive, Greenlight, and ApplyBoard. The firm is stage-agnostic, investing in seed, early-stage, and later-stage companies across various sectors such as healthcare, consumer services, information technology, and life sciences. The firm operates with a strong conviction in the potential of entrepreneurs from non-traditional tech hubs and emphasizes long-term partnerships. They seek out market-defining companies and prefer to journey with their portfolio companies from inception to IPO. Drive Capital's strategy is deeply rooted in leveraging local talent and resources, ensuring startups have the best advantages by building where they are strongest. Drive Capital's team includes a diverse group of investors committed to supporting founders with honesty and strategic guidance. They maintain a robust network and offer substantial resources to help startups navigate their growth trajectories. For entrepreneurs looking to engage with Drive Capital, the firm values bold, innovative ideas that address large market opportunities and demonstrate potential for significant impact​.

Droia Ventures is a Belgium-based venture capital firm that specializes in early-stage biotech investments, focusing exclusively on oncology and genetic diseases. With over €450 million under management, Droia supports young drug development companies that leverage cutting-edge science to bring breakthrough therapies to patients. Their portfolio includes companies such as Actio Biosciences and Vicinitas Therapeutics, which are focused on drug discovery in these high-impact areas. The firm’s investment strategy is highly targeted, aiming to fill the unmet medical needs in cancer treatment and genetic diseases like cystic fibrosis and hemophilia. Droia’s funds typically invest in newly founded or early-stage platform companies, often providing both financial backing and scientific expertise to help startups develop first-in-class drug candidates. Droia’s global reach is evident in its investments across the U.S. and Europe, with check sizes typically in the seed and early venture stages. Led by experienced partners like Janwillem Naesens and industry veteran George Golumbeski, Droia emphasizes long-term partnerships and active involvement in the scientific and business growth of its portfolio companies​.

DSM Venturing, the corporate venture arm of DSM, focuses on investing in innovative startups that align with its mission of improving health, nutrition, and bioscience. Since its inception in 2001, DSM Venturing has invested in over 100 startups across these sectors. Their portfolio includes companies such as NutriLeads, which develops food ingredients with health benefits, and Deep Branch Biotechnology, which converts carbon dioxide into sustainable animal nutrition products. Geographically, DSM Venturing is particularly active in North America and Europe. They typically invest between €1 million and €20 million over the lifetime of a venture, starting with initial investments ranging from €100k to €5 million. They take minority ownership stakes and often lead investment rounds while actively participating in the board activities of their portfolio companies​. DSM Venturing's investment strategy focuses on startups that offer transformative solutions in health, nutrition, and care, as well as animal nutrition and health, and food innovation. They aim to support these companies not only with funding but also with access to DSM's extensive scientific and commercial resources, fostering innovations that have the potential to make significant societal impacts​.

The goal of DuPont Ventures is to foster innovation by investing in early-stage startups that align with DuPont’s core areas of focus—advanced materials, biosciences, electronics, and sustainability. The venture arm helps DuPont stay on the cutting edge by engaging with innovative companies that bring disruptive technologies and solutions to market. DuPont Ventures seeks to collaborate with startups that complement its existing R&D efforts, leveraging the company’s vast resources in scientific research, engineering, and market reach. The focus is on strategic investments that can accelerate DuPont’s innovations, particularly in fields like industrial biotechnology, electronics, clean technologies, and agriculture. Startups benefit from DuPont’s global infrastructure, access to technical expertise, and opportunities to scale through DuPont’s commercial channels. The venture team looks for startups that are pushing boundaries in science and technology, providing them with both capital and strategic guidance to foster growth. In doing so, DuPont maintains a forward-looking approach, ensuring it remains competitive and continues to innovate across its key sectors. Through these strategic investments, DuPont Ventures plays a key role in expanding the company’s innovation portfolio, tapping into external talent and groundbreaking technologies that shape the future of industries.

Duro Ventures, founded in 2013 and based in San Francisco, is a venture capital firm with a broad investment portfolio that spans sectors like health, education, consumer products, and technology. The firm has a strong focus on backing mission-driven founders and companies making meaningful impacts, including in emerging areas like blockchain and VR. Some notable portfolio companies include Substack, Elroy Air, AirByte, and OpenSea, illustrating their diverse interests in consumer tech, logistics, and Web3. Duro Ventures typically invests between $10,000 and $500,000, targeting early-stage startups across industries like healthcare, commerce, and education. Their health-focused investments include Notable (personalized cancer treatment) and OssoVR (VR surgical training). Additionally, the firm has a growing emphasis on climate tech and social impact ventures. The fund is led by Edward Hu and Milan Thakor, who bring deep expertise in technology and startups. With a reputation for being founder-friendly, Duro Ventures is known for its supportive approach, often co-investing with well-known firms like Y Combinator and Gaingels. They’re actively shaping a future that balances profitability with positive global change.

Dux Capital is an early-stage venture capital firm founded in 2017, with a focus on supporting Latinx entrepreneurs. Based in both Austin, Texas, and Mexico City, Mexico, Dux Capital aims to bridge the funding gap for Latinx founders by investing in diverse and emerging startups that have strong growth potential and impact. The firm is led by co-founders Daniel Santamarina and José Luis Silva, who are committed to providing strategic capital and support to Hispanic-Latino entrepreneurs. Dux Capital recently achieved a significant milestone with the first close of its second fund, which attracted investments from prominent Hispanic-Latino investors and was led by Bank of America. This new fund builds on the success of their first fund and aims to continue addressing the funding disparities faced by Latinx founders. Dux Capital's investment strategy focuses on seed-stage companies across various sectors, including enterprise applications, high tech, edtech, healthtech, and fintech. Some of their notable investments include Mozper, Innovare Social Innovation Partners, and Atexto. They are known for their cross-border approach, enabling their portfolio companies to scale and succeed across different markets. The firm’s commitment to empowering Latinx entrepreneurs and its strategic partnerships underscore its role in fostering innovation and economic growth within the Latinx community.

DvH Ventures is a leading European early-stage venture capital firm based in Cologne, Germany. The firm focuses on investing in digital technology startups, with particular emphasis on sectors such as fintech, insurtech, artificial intelligence, cybersecurity, and digital health. DvH Ventures aims to support and partner with innovative companies that develop disruptive products and services. The firm operates multiple funds, including the Digital Tech Fund (DvH Ventures Fund III) and the Digital Health Fund (DvH Ventures Fund IV). The Digital Health Fund, launched in 2020 with a €70 million capital, invests across Europe in technologies that address future healthcare challenges. DvH Ventures typically invests up to €2 million in early-stage companies and often acts as the lead investor, providing follow-on capital and strategic support to its portfolio companies. DvH Ventures prides itself on being more than just a financial investor; it offers extensive operational expertise and a robust network, including media-for-equity services through partnerships with prominent media brands like Handelsblatt and DIE ZEIT. The firm is committed to fostering a collaborative and entrepreneurial environment, ensuring close and trusting interactions with founders and partners.

Dynamk Capital is a New York-based venture capital firm that specializes in investing in early-stage companies within the life sciences sector, particularly focusing on life science industrials. Established in 2016, Dynamk Capital targets startups that develop critical tools, technologies, and services essential for the discovery, development, and manufacturing of life-saving therapies. The firm plays a pivotal role in advancing innovative solutions across the biopharma continuum, from drug discovery to development and production. Dynamk Capital's investment strategy is centered around providing both capital and strategic support to early-stage companies, helping them scale and succeed in a highly competitive and complex industry. The firm's portfolio includes a diverse range of companies, such as RoosterBio, which specializes in cell and exosome manufacturing, and Virica Biotech, which focuses on enhancing viral vector manufacturing for gene therapy. These investments reflect Dynamk's commitment to driving innovation in biomanufacturing and life sciences. The firm recently closed its inaugural life sciences fund at $65 million, marking a significant milestone in its mission to support groundbreaking life science ventures. Dynamk Capital continues to be an active player in the venture capital space, leveraging its industry expertise to identify and nurture companies that have the potential to make substantial contributions to healthcare and biopharmaceutical advancements.

Dynamo Ventures, established in 2016 and headquartered in Chattanooga, Tennessee, is a seed-stage venture capital firm that focuses on supply chain and mobility technology. The firm is known for investing in startups that address critical issues in the logistics, transportation, and supply chain sectors. Dynamo Ventures typically invests between $250,000 and $1.2 million per seed-stage company. Their notable portfolio includes Sennder, a German digital freight brokerage that recently achieved unicorn status with a valuation of $1.45 billion. Other significant investments are STORD, a digital warehouse and distribution network based in Atlanta, and Shipamax, a digital platform for bulk shipping. Additionally, they have backed companies like Skupos, a data analytics platform for convenience stores, and Celadyne Technologies, which focuses on advanced materials for batteries. Dynamo's investment strategy is centered around providing not only capital but also extensive industry expertise and network connections to help their portfolio companies succeed. The firm recently raised $43.21 million for their second fund, more than doubling the size of their first fund, which indicates strong investor confidence in their focused approach.

E²JDJ is a venture capital fund at the forefront of food and agriculture innovation, co-founded by Corey Jones and Stephanie Dorsey. With a mission to transform the global food production system, E²JDJ invests in early-stage startups pioneering breakthroughs in computational biology, chemistry, and physics to create more efficient, sustainable, and prosperous food solutions. The fund is particularly focused on companies that address critical challenges such as food security, environmental impact, and resource efficiency. E²JDJ’s portfolio showcases a diverse array of companies that are pushing the boundaries of food technology, including ventures in alternative proteins, precision fermentation, and digital agriculture. Geographically, the fund primarily focuses on investments within the United States but is open to global opportunities that align with its mission. The investment strategy at E²JDJ is centered around identifying transformative technologies with the potential to scale rapidly and disrupt traditional food systems. The firm typically participates in seed and Series A rounds, providing not only capital but also strategic guidance and a deep network of industry connections. E²JDJ’s founders bring a wealth of experience in both venture capital and the food industry, with Stephanie Dorsey having a background in sustainable agriculture and Corey Jones specializing in tech-driven ventures. The team’s combined expertise ensures that they can provide valuable insights and support to their portfolio companies. Startups seeking investment from E²JDJ are advised to highlight their innovative technology, clear path to scalability, and potential for significant impact on the food industry.

E2MC is a venture capital firm dedicated to investing in the burgeoning space economy. Founded by Raphael Roettgen, a seasoned investor and space enthusiast, E2MC focuses on early-stage investments in space-related technologies and businesses. The firm is committed to supporting the development of innovative solutions that can unlock new opportunities in space exploration, satellite technology, space-based data services, and other emerging sectors within the space industry. E2MC's investment strategy is driven by the belief that the space economy is poised for significant growth and that the technologies being developed today will have far-reaching impacts on various industries, including telecommunications, agriculture, climate monitoring, and defense. By backing visionary entrepreneurs and groundbreaking technologies, E2MC aims to play a pivotal role in shaping the future of space exploration and utilization. The firm operates with a global perspective, seeking out investment opportunities across different geographies and collaborating with a diverse network of industry experts, researchers, and policymakers. E2MC is particularly interested in companies that are addressing key challenges in space, such as reducing the cost of access to space, enhancing satellite capabilities, and developing sustainable practices for space exploration. With its deep expertise in both finance and space technology, E2MC provides not just capital but also strategic guidance and support to help its portfolio companies navigate the unique challenges of the space industry. The firm is committed to driving innovation in space while generating strong financial returns for its investors.

Eagle Venture Fund is a venture capital firm based in Fort Worth, Texas, with additional offices in Zurich and Singapore. Founded with a mission to drive both financial returns and significant social impact, Eagle Venture Fund focuses on early-stage investments in startups that tackle major societal challenges such as human trafficking, poverty, and healthcare for underserved populations. The firm operates several funds, including the Eagle Venture Fund IV, Eagle Freedom Fund, and Eagle City Fund. These funds support companies that are not only profitable but also dedicated to creating sustainable and exponential impacts. For example, the Eagle Freedom Fund specifically targets initiatives combating modern slavery and human trafficking. Eagle's investment approach is deeply integrated with their Venture Builder Engine, which provides startups with extensive support in areas such as strategic counsel and founder development. This hands-on approach helps portfolio companies scale effectively while staying true to their mission-driven goals. The leadership team at Eagle includes experienced professionals like Wes Lyons and Wade Myers, who bring a wealth of experience in both venture capital and impact investing. The firm has built a strong reputation for backing bold entrepreneurs who are passionate about creating change in areas where it’s most needed​.

Early Light Ventures (ELV) is a venture capital firm founded in 2019, primarily investing in early-stage B2B SaaS companies. With around $37 million under management, the firm focuses on backing underdog founders who exhibit grit and ambition, especially those building in data-driven business applications, the future of work, and learning technologies. ELV is headquartered in the Mid-Atlantic region, but its portfolio companies extend across the U.S., with notable investments in startups like Sorcero, Workstream, and LearnLux. The firm seeks to empower non-traditional entrepreneurs by evaluating startups based on merit rather than established credentials or connections. ELV emphasizes speed and conviction, often closing deals within days. They specialize in capital-efficient companies, aiming to support founders regardless of whether they are pursuing billion-dollar exits. Instead, their priority is enabling founders to "win" on their own terms, ensuring sustainable growth and successful outcomes. Led by a team of experienced entrepreneurs and investors like Scott Garber, Sam Diener, and Greg Cangialosi, ELV provides not only financial backing but also strategic advice, leveraging their extensive network to connect startups with other investors, key hires, and growth opportunities. Their approach to venture capital is highly founder-friendly, focusing on collaboration, integrity, and rapid execution to help startups scale efficiently and effectively.

Earlybird Venture Capital, founded in 1997, is a leading European venture capital firm with a strong focus on technology innovators. They manage around €2 billion in assets and have invested in over 220 companies across various sectors including digital technologies, healthcare, and deep tech. Earlybird operates four specialized funds: Digital West, Digital East, Health, and Earlybird-X, each targeting different geographies and technological areas. Notable investments include UiPath, a global leader in robotic process automation, and N26, a mobile banking platform. Earlybird has achieved significant exits through IPOs and trade sales, contributing to its reputation as one of Europe’s most experienced venture investors. Earlybird's strategy involves not only providing financial resources but also strategic support and access to an international network, aiding portfolio companies in scaling and succeeding in global markets. The firm is committed to sustainable practices and expects the same from its portfolio companies. For startups looking to engage with Earlybird, demonstrating innovative technology and scalability, particularly within Europe, can increase the likelihood of securing investment. The firm’s hands-on approach and extensive network provide substantial support to their portfolio companies, fostering growth and market success.

Earthshot Ventures is a climate-focused venture capital firm committed to scaling solutions that address climate change across key sectors: energy, food systems, mobility, and industry. Founded in 2021 and led by climate tech veterans like Mike Jackson and Dawn Lippert, the fund seeks investments from Pre-Seed to Series B, targeting startups with both commercial promise and environmental impact. With $50-99M in assets under management, Earthshot leverages deep industry expertise and extensive networks, including Elemental Excelerator’s pipeline of over 800 companies annually, to identify and scale groundbreaking technologies. Their portfolio includes innovative companies like Lilac Solutions, which has developed a more sustainable method for lithium extraction, and Planet FWD, a carbon management platform for consumer brands. Other notable investments include Halo Car, which offers an all-electric ride-hail experience, and Kanin Energy, streamlining decarbonization efforts for the industrial sector. Earthshot's approach centers on catalyzing significant climate impact while also delivering above-market financial returns. Operating across the U.S. and Canada, Earthshot Ventures provides not only capital but also strategic support and access to a global network of partners and investors, making them a critical player in the climate tech ecosystem.

East Ventures is one of Southeast Asia's most active venture capital firms, known for backing some of the region's most successful startups. With investments in Tokopedia, Traveloka, Xendit, and Carro, it has a strong track record of nurturing unicorns. The firm primarily focuses on sectors like fintech, healthcare, SaaS, and logistics, with an emphasis on Indonesia, where it helps drive digital and economic growth. Recent investments include AWST (Web3), McEasy (telematics), and Rekosistem (waste management), reflecting its broad sectoral interest. East Ventures typically invests at the seed stage but also participates in growth rounds through its EV Growth Fund. It operates across multiple locations, including Jakarta, Singapore, and Japan, and is deeply committed to sustainability, with goals like achieving net-zero emissions by 2050. The firm supports ESG initiatives across its portfolio and actively engages in environmental projects such as mangrove reforestation. Co-founded by Willson Cuaca, Roderick Purwana, and Melisa Irene, East Ventures is recognized globally, having been ranked among the most active VCs by Pitchbook and CB Insights. The firm maintains a founder-centric philosophy, investing in people and markets over products, which has been key to its long-term success.

East West Capital, based in Sydney, Australia, is a venture capital firm that specializes in early-stage investments across biotechnology, synthetic textiles, and emerging technologies. Founded in 2005, the firm has become a key player in identifying and nurturing disruptive innovations. East West Capital has a global reach and is known for backing companies like Bolt Threads, a leader in synthetic materials used in fashion and textiles, as well as eCal Corporation, a tech company focused on SaaS solutions​. The firm’s investment strategy is highly collaborative, often co-investing with other leading venture funds. East West Capital has participated in rounds alongside renowned investors such as Founders Fund and Innovation Endeavors, making strategic contributions to high-growth startups. It typically invests in sectors that are at the forefront of technological evolution, including consumer products, health tech, and advanced manufacturing. East West Capital's portfolio reflects its focus on companies that combine technology and real-world applications. Notable sectors include biotech innovations aimed at revolutionizing healthcare, as well as tech-driven consumer goods. With an average round size of $29 million, the firm targets early-stage companies that demonstrate both strong growth potential and technological innovation​. With a strong foundation in Australia and a global investment perspective, East West Capital continues to shape the future of technology and innovation, contributing to the growth of groundbreaking companies both domestically and internationally.

Eatable Adventures, founded in 2015, is a Madrid-based venture capital and accelerator firm focused on driving innovation within the food and agriculture technology sectors. The firm supports early and growth-stage startups that are revolutionizing the agri-food value chain with sustainable, scalable solutions. Eatable Adventures has made a significant impact with its €50 million Eatable Evolution Fund FCR I, one of the largest food-tech funds in Europe. This fund targets disruptive food-tech startups across Europe and Latin America, making strategic investments to tackle critical challenges like food waste, sustainability, and resource efficiency. Eatable Adventures operates numerous accelerator and incubation programs globally, including Spain Foodtech, FoodSeed in Italy, and Mylkcubator, the world’s first dairy-focused incubation program. The firm’s portfolio includes innovative companies like Cocuus, which uses 3D printing to create hyper-realistic plant-based meats, and Proppos, which employs AI for food service automation. Led by founder José Luis Cabañero and managing partner Mila Valcárcel, Eatable Adventures blends deep industry knowledge with a hands-on approach, helping startups refine their business models, scale operations, and connect with industrial partners. With a strong presence in Spain and Italy and a growing footprint across Europe and Latin America, Eatable Adventures is at the forefront of food-tech innovation, working to build a more sustainable future for the global food system.

eCAPITAL is a leading venture capital firm based in Münster, Germany, specializing in high-tech and innovative industries. Their portfolio includes notable investments such as Open-Xchange, a pioneer in software and IT; 1Komma5°, a leader in cleantech; and Jedox, a prominent name in enterprise software. The fund focuses on sectors like cleantech, cybersecurity, new materials, Industry 4.0, and software/IT, targeting startups that drive technological advancements. Geographically, eCAPITAL primarily invests in companies based in Europe, leveraging Germany's robust tech ecosystem. Their investment strategy involves providing significant capital for growth, with average check sizes around €120 million. They prefer to co-invest rather than lead rounds, fostering strong collaborations with other investors. Led by seasoned experts like CEO Paul-Josef Patt, who has over two decades of experience in the VC space, and partners such as Dirk Seewald and Katharina Frie, eCAPITAL combines deep industry knowledge with a proactive support approach. They have a keen eye for transformative technologies and are known for their rigorous due diligence and strategic guidance. Startups seeking funding are advised to approach eCAPITAL with a clear demonstration of their technological edge and market potential. The firm values innovative solutions that address significant market needs and have the potential for global impact. Their active involvement in the startup ecosystem ensures they remain at the forefront of technological innovations, making them a vital partner for ambitious high-tech ventures.

Eclipse Ventures, founded in 2015 and headquartered in Palo Alto, California, is a venture capital firm that focuses on transforming essential industries through innovative technology. The firm has over $2 billion in assets under management and invests in sectors such as manufacturing, logistics, supply chain, energy, healthcare, and transportation. Notable investments in their portfolio include VulcanForms, which develops advanced digital manufacturing infrastructure; Augury, providing machine health insights; Enovix, designing advanced lithium-ion batteries; and Cellares, which offers scalable cell therapy manufacturing solutions. Eclipse Ventures has made over 108 investments and has seen 11 successful exits, including companies like Light and Veev. The firm typically invests across various stages, from pre-seed to Series D, and aims to modernize physical industries that are critical to the economy. Their team is composed of experienced operators and investors who provide strategic support and resources to help portfolio companies grow and succeed.

eHealth Ventures, founded in 2014, is a digital health-focused venture capital firm based in Israel. It primarily invests in early-stage startups, focusing on innovative technologies that drive the transition from hospital care to home care and predictive healthcare solutions. With over $70 million in assets under management, the firm operates a unique investment structure, providing both capital and extensive support to its portfolio companies. Their investments target pre-seed to early-stage rounds, often leveraging non-dilutive funding from the Israeli Innovation Authority. eHealth Ventures boasts a diverse portfolio of over 30 startups, including companies like AccuLine, which is developing a non-invasive heart attack detection test, and GaitBetter, an AI-driven platform for fall prevention and rehabilitation. The firm’s strategic partnerships with healthcare heavyweights such as Maccabi Healthcare Services, Amgen Ventures, and the Mayo Clinic allow its portfolio companies access to vast medical networks and commercial opportunities across the globe. Led by CEO Talor Sax, eHealth Ventures plays a pivotal role in nurturing digital health startups, providing hands-on guidance from the early stages through to commercialization. The firm’s mission is to address pressing healthcare challenges by investing in solutions that improve accessibility, reduce costs, and enhance patient care. Its approach is deeply rooted in collaboration, bringing together industry leaders, healthcare providers, and technologists to shape the future of digital health.

Eiffel Investment Group is an asset management firm based in Paris, established in 2009 within the Louis Dreyfus Group and now operating independently. Specializing in sustainable investments, Eiffel manages over €4 billion in assets across various strategies, including private debt, energy transition infrastructure, private equity, and listed equities and credit. The firm is committed to ESG (Environmental, Social, and Governance) principles, actively engaging with portfolio companies to enhance their ESG practices. The Eiffel NOVA Midcap ISR fund, targeting innovative European mid-cap stocks, has received an SRI (Socially Responsible Investment) label, reflecting its responsible management process. Eiffel collaborates with major institutional investors and entities like the European Investment Fund to support renewable energy and sustainable projects. This includes pioneering equity bridge solutions for financing renewable energy infrastructures. Overall, Eiffel Investment Group is a significant player in advancing the energy transition and supporting the growth of SMEs in Europe through its strategic focus on sustainability and robust network.

Eight Roads Ventures, founded in 1969, is a global venture capital firm and the corporate investment arm of Fidelity International. The firm manages over $11 billion in assets and has a significant presence in major markets including the UK, China, India, Japan, and the US. Eight Roads focuses on investing in technology and healthcare sectors, backing companies from early to growth stages. Eight Roads has built an impressive portfolio with over 300 active companies and 19 unicorns, including notable names like AppsFlyer, Icertis, and Akulaku. The firm is also known for its strong support network, providing not just capital but also strategic guidance and resources to help its portfolio companies scale globally. The firm recently launched a $375 million fund focused on Europe and Israel, targeting sectors such as enterprise technology, consumer, fintech, and healthcare IT. This fund aims to make 15 to 20 investments of $10 million to $30 million each​. Eight Roads' team includes seasoned professionals like Daniel Auerbach, Senior Managing Partner & Head of Global Ventures, and Jarlon Tsang, Managing Partner & Head of China, who bring extensive experience and expertise to the firm's operations.

Eka Ventures is a London-based venture capital firm founded in 2018 by Camilla Dolan, Jon Coker, and Andrew Richardson. The firm is dedicated to investing in early-stage startups that aim to create a positive system change, focusing on companies that promote sustainability, health, and inclusivity. Eka Ventures primarily invests in the seed and Series A stages, with typical check sizes ranging from £0.5 million to £3 million. The firm’s portfolio includes a diverse range of companies, such as Byway, a sustainable travel platform, and Hived, a green logistics startup. Eka Ventures is particularly interested in technology-driven businesses that leverage data and science to build solutions that can scale and make a significant impact on the economy and environment. Eka’s strategy revolves around partnering with mission-driven founders who are building category-defining technology companies. The firm is known for its hands-on approach, working closely with founders to support their growth and scale their businesses. With all of its team members based in London, the firm emphasizes a collaborative and supportive environment, providing not only capital but also strategic guidance and operational support. For startups seeking investment, Eka Ventures values a clear mission-driven approach that aligns with their focus on sustainability and positive impact. The firm’s founders have a strong background in consumer technology and a deep commitment to backing companies that aim to solve critical global challenges.

eLab Ventures is a venture capital firm focused on early-stage technology startups, particularly those leveraging artificial intelligence to create market disruption. Established in 2012, the firm is strategically located in both Ann Arbor, Michigan, and Silicon Valley, California, allowing it to bridge innovation from emerging markets to key entrepreneurial hubs. eLab Ventures primarily invests at the pre-seed, seed, and Series A stages. Notable portfolio companies include Refraction AI, MemryX, and Voxel51, showcasing their commitment to backing startups with disruptive technologies and exceptional teams. The firm emphasizes capital-efficient business models with the potential to serve large markets. Key team members include co-founders Doug Neal and Bob Stefanski. Doug Neal, based in Ann Arbor, brings over 20 years of tech industry experience, including founding and leading Mobile Automation. Bob Stefanski, based in Silicon Valley, has extensive experience in technology entrepreneurship and venture capital, having co-founded TIBCO Software and served in various leadership roles. eLab Ventures supports its portfolio companies by providing access to capital, expertise, and a strong network of advisors. The firm is dedicated to nurturing world-changing ideas and contributing to the growth of the entrepreneurial ecosystem both in the Midwest and beyond​.

Elaia Partners is a leading European venture capital firm focused on investing in digital and deep tech startups from early-stage to growth development. Founded in 2002 and headquartered in Paris, Elaia manages over €700 million in assets. The firm has built a strong reputation for backing ambitious tech entrepreneurs, with notable investments in companies like Mirakl, Shift Technology, Ornikar, and iBanFirst. Elaia's investment strategy emphasizes supporting disruptive technologies and innovative business models across various sectors, including SaaS, AI, fintech, and health tech. They typically invest in early-stage companies with high growth potential, providing both capital and strategic guidance to help these startups scale globally. Their portfolio includes over 100 investments and 80 successful exits, showcasing their ability to identify and nurture high-potential startups. The firm is known for its close relationships with deep tech academia and its commitment to ESG principles. Elaia's team consists of experienced investors and entrepreneurs who work closely with portfolio companies to drive growth and achieve long-term success. The firm's recent launch of the Elaia Delta Fund, which secured €115 million in its initial closing, underscores their ongoing commitment to supporting tech disruptors.

Elemental Excelerator, based in Honolulu and San Francisco, is a nonprofit investor focusing on scaling climate technologies and fostering social equity solutions. Since its inception in 2009, the firm has supported over 150 companies across various sectors, including energy, water, agriculture, mobility, and circular economy. Notable investments in Elemental Excelerator's portfolio include CarbonCure, which injects CO2 into concrete to permanently store carbon, and FreeWire Technologies, specializing in flexible, fast-charging technology for electric vehicles. Other significant investments are Zero Mass Water, which produces drinking water from air using solar-powered hydropanels, and Proterra, a manufacturer of electric buses. The firm emphasizes a blend of project finance and venture capital to support its portfolio companies, helping them scale rapidly and achieve impactful results. Elemental Excelerator also partners with major corporations and investors to provide comprehensive support to its startups, facilitating growth and innovation in the climate tech space.

Elementum Ventures, founded in 2014 and based in Menlo Park, California, is a venture capital firm that focuses on investing in seed-stage deep technology companies. The firm targets large markets with intellectual property as their primary differentiation and defensibility, emphasizing emerging technologies that are on the cusp of commercialization. They provide not only capital but also strategic support through their network of strategic partners, advisors, and potential customers. Elementum Ventures has a notable portfolio that includes companies like Anduril, a defense technology company, and Fathom Radiant, which works on advanced AI hardware. They also invest in diverse sectors such as consumer products, virtual reality, augmented reality, artificial intelligence, and machine learning. The firm's team includes General Partners Ben Chelf, Ben Patterson, and Kurt Keilhacker. Ben Chelf co-founded Coverity, which was later acquired by Synopsys. Ben Patterson has a background in music and IT infrastructure, while Kurt Keilhacker has co-founded and invested in over 50 companies across the US and Europe. For startups looking to engage with Elementum Ventures, demonstrating strong intellectual property and the potential for significant market impact can be advantageous. The firm's deep involvement and extensive network support can provide significant value to early-stage ventures​.

Elev8.vc is a Singapore-based venture capital firm that focuses on early-stage investments in deep tech startups. The firm is dedicated to supporting founders who are developing groundbreaking technologies across sectors such as complex computing, novel materials, smart mobility, and medtech. Elev8.vc’s investment philosophy is centered on backing companies that not only promise significant commercial success but also drive transformative changes in their respective industries. Elev8.vc's portfolio reflects its commitment to innovation, featuring companies like PreAct Technologies, which is developing advanced automotive safety systems, and Polybee, which uses drones and AI to automate pollination for increased agricultural efficiency. Other notable investments include Entropica Labs, a quantum computing startup, and UNL, a platform that provides precise location-based services. The firm’s leadership team, led by Managing Director Aditya Mathur, brings a wealth of experience in both investment and operational roles, ensuring that portfolio companies receive not just financial backing but also strategic guidance and access to a vast network of industry contacts. Elev8.vc is particularly focused on helping startups scale globally, leveraging its strong connections across Asia and beyond.

Elevat3 Capital is the venture capital arm of Christian Angermayer's Apeiron Investment Group, a global investment firm with over $2.5 billion in assets under management. Elevat3 focuses on investing in high-growth technology companies across Europe, often leading or co-leading rounds with ticket sizes ranging from $5 million to $20 million. The firm targets industries undergoing significant change, particularly in sectors like life sciences, fintech, and future technologies. The team at Elevat3 is known for its hands-on approach, providing strategic support beyond just capital to help portfolio companies scale effectively. With a presence in key locations like Berlin, London, and New York, Elevat3 leverages a robust network and deep industry expertise to drive value creation in its investments. Some of the notable investments include Gropyus, a company focused on sustainable building technologies, and Formo, which is pioneering the production of cultured dairy products. The firm’s investment strategy emphasizes finding and activating key "triggers" that can significantly elevate a company’s valuation and market position.

Elevate Capital is a pioneering venture capital fund with a mission to support underserved entrepreneurs, including women, minorities, veterans, and those with limited regional access to capital. Since its launch in 2016, Elevate has made significant investments in diverse founders across various industries such as healthcare, fintech, cybersecurity, and SaaS. Notable investments include startups like Troy Medicare and Blendoor. Focusing on pre-seed to Series A stages, Elevate typically invests between $25k to $2 million. Their strategic emphasis is on scalable startups founded by underrepresented groups, aiming to foster generational wealth and economic impact. They primarily target companies in Oregon through the Innovation Gap Fund, but their Capital Fund II extends investments nationally. The fund's approach is deeply rooted in active mentorship and hands-on support, leveraging the extensive experience of its team members. Key figures include Managing Partner Nitin Rai, who is instrumental in guiding the fund's inclusive investment strategy. Other notable team members are Lateef Jackson, focusing on healthcare technology, and Giovanni, who brings expertise in global strategy and market development. Elevate Capital's proactive outreach and strategic networking are key elements in building their investment funnel. Entrepreneurs are encouraged to approach them via warm introductions or direct contact through their website. By prioritizing diversity and inclusion, Elevate Capital stands out in the venture capital landscape, driving meaningful change and supporting the next generation of visionary founders.

Elevate Ventures is a leading venture capital firm based in Indianapolis, Indiana, specializing in early-stage investments across various sectors. Since its founding in 2011, Elevate has established itself as the top seed and early-stage VC firm in the Great Lakes region, and among the top 20 globally. The firm primarily targets Pre-Seed, Seed, and Series A startups, focusing on companies that are innovation-driven and have a total addressable market (TAM) of at least $500 million. Elevate Ventures is dedicated to supporting Indiana's entrepreneurial ecosystem, investing over $152 million in more than 500 startups since its inception, while leveraging an additional $2 billion in co-investment from private capital. The firm is highly active in sectors such as business software, financial technology, and life sciences, with notable investments in companies like RootNote and Acoustic Technologies. The firm's investment strategy is centered on collaboration, providing not only capital but also hands-on mentorship, network access, and strategic resources. This approach includes initiatives like Elevate+, which supports startups post-investment with resources for growth, and the recently announced $100 million entrepreneurship fund aimed at helping Indiana-based companies scale further​.

Embark Ventures, based in Santa Monica, California, is a venture capital firm specializing in pre-seed and seed-stage investments. Founded in 2017 by Peter Lee and Yipeng Zhao, the firm focuses on "deep tech" companies that possess proprietary technology offering a significant competitive advantage in transforming multi-billion dollar industries. The sectors they target include bio-healthcare, software and computing, manufacturing and industrial, material science, robotics and automation, and sensors and semiconductors​. Embark Ventures has made numerous notable investments, including companies like Truvian Sciences, Parallel Systems, Kula Bio, and Machina Labs. Their strategy involves backing ambitious teams with breakthrough technologies that can disrupt large markets. The firm typically invests between $100,000 and $2 million in their portfolio companies​.

Emerald Technology Ventures, founded in 2000, is a prominent venture capital firm based in Zurich, Switzerland, with offices in Toronto and Singapore. The firm specializes in investments in clean technology, targeting sectors such as energy, water, wastewater, materials, packaging, mobility, urbanization, food, and agriculture. With assets under management exceeding €1 billion, Emerald has made significant contributions to the advancement of sustainable technologies. Emerald's portfolio includes a variety of innovative companies. Notable investments include SewerAI, a leader in AI and cloud-driven sewer condition assessment, and SpotLight, which develops non-invasive subsurface surveillance solutions for carbon dioxide geological storage. Other significant investments are in companies like Kalpana Systems and VYTAL, which focus on semiconductor technology and reusable packaging solutions, respectively. The firm has also achieved successful exits with companies such as Rhombus Energy Solutions, DeepSea Technologies, and Spear Power Systems, showcasing its ability to nurture and scale startups towards successful outcomes. Emerald's investment strategy is driven by a commitment to tackling major challenges in climate change and sustainability, leveraging their expertise and extensive network to support groundbreaking innovations in these fields. Emerald's team comprises experienced professionals, including Hans Dellenbach, Markus Moor, and Christoph Frei, who bring a wealth of knowledge and strategic insight to their portfolio companies. Their approach combines financial investment with strategic support, ensuring that their portfolio companies can thrive and make a substantial impact on their respective industries.

Emerald Technology Ventures, founded in 2000 and headquartered in Zurich, Switzerland, is a leading venture capital firm focused on sustainable industrial innovation. With over €1 billion in assets under management, Emerald invests in early-stage companies addressing global challenges through advanced technologies in sectors like energy, water, advanced materials, and industrial IT. The firm has a diverse portfolio that includes companies such as SewerAI, which leverages AI and cloud technology for sewer inspection and management, and Genecis, a company converting food waste into biodegradable plastics. Other notable investments include Imagindairy, which produces animal-free milk proteins, and Paptic, a company developing sustainable fiber-based materials as alternatives to plastics. Emerald has a track record of successful exits, including DeepSea Technologies, Spear Power Systems, and Rhombus Energy Solutions. They focus on providing not just capital but also strategic support, leveraging their extensive network and industry expertise to help portfolio companies scale and achieve significant impact. Emerald's team, led by CEO Gina Domanig, consists of professionals with deep experience in venture capital, technology, and sustainability. The firm's commitment to sustainable innovation aims to drive transformative change in industries critical to achieving a net-zero emissions future.

Emerson Collective, founded by Laurene Powell Jobs, is a unique blend of philanthropy and impact investing focused on education, immigration, the environment, media, and health. Notable investments include AltSchool, College Track, and XQ Institute, emphasizing their commitment to transforming education and creating social impact. They invest globally but have a strong presence in the US. Their strategy involves partnering with innovative entrepreneurs and providing not just capital but also strategic support to scale impactful solutions. The team is composed of experts from various fields, ensuring a comprehensive approach to addressing complex social issues.

Empede Capital is a venture capital firm established in 2021, with a focus on disruptive technologies across various sectors. Headquartered in Tortola, British Virgin Islands, with additional offices in the UAE and the UK, Empede Capital primarily invests in Seed to Series B startups. The firm’s expertise spans industries like cyber technology, construction technology, healthcare, agriculture, fintech, cloud, virtual reality, drone technology, and more. Empede Capital emphasizes innovation and scalability, investing in companies that leverage emerging technologies to disrupt traditional industries. Some of its notable portfolio investments include Instacart, Better.com, Digital Ocean, and Axiom Space. The firm's founding partners, including Mukund Hirani, Prakash Senghani, Raj Varsani, and Dinesh Dabasia, bring extensive experience from sectors like cyber, real estate, and construction, which they use to provide both financial support and strategic guidance to the startups they back. Empede Capital's approach focuses on providing "smart capital," leveraging its domain expertise to help companies scale and achieve industry disruption.

Empirical Ventures is a UK-based venture capital firm that focuses on deep science startups at the pre-seed and seed stages. Their core investments lie in sectors such as life sciences, advanced materials, robotics, quantum technologies, and energy transition. Notable portfolio companies include Anaphite (electric vehicle batteries), QV Bioelectronics (glioblastoma treatment devices), and Albotherm (sustainable cooling technologies). Founded by scientists Dr. Ben Miles and Dr. Johnathan Matlock, both with a strong entrepreneurial background in deep science, the firm is deeply involved in the UK’s deep tech ecosystem. They bring extensive due diligence capabilities to de-risk early-stage investments, providing both capital and operational support to startups. The firm is known to lead funding rounds with initial investments of £250k to £350k, while also participating in follow-on rounds. Empirical Ventures' investment strategy is focused on companies that are IP-rich, built on fundamental scientific research, and that have potential to solve pressing societal issues, particularly in climate and healthcare. They prefer UK-based startups that qualify for S/EIS tax relief and encourage pitches with strong scientific foundations. The fund aims to raise £10M to bolster this high-impact portfolio and continues to grow its influence in the deep tech landscape.